Tea () infusions ameliorate cancer in  metastatic breast cancer model by unknown
RESEARCH ARTICLE Open Access
Tea (Camellia sinensis) infusions ameliorate
cancer in 4TI metastatic breast cancer
model
Karori S. Mbuthia1*, Paul O. Mireji2, Raphael M. Ngure3, Francesca Stomeo4, Martina Kyallo4, Chalo Muoki5
and Francis N. Wachira6
Abstract
Background: Tea (Camellia sinensis) infusions are widely consumed beverages with numerous health benefits.
However, physiological and molecular responses mediating these activities are poorly understood.
Method: Three replicates of 4TI cancer cell suspension (2.0 × 105 cells/ml) were challenged in vitro with various
concentrations of green, black and purple tea infusions to asseses their cytoxicity and associated differentially expressed
genes in the cells. Inhibitory activity was tested by using serial dilutions of respective tea infusions in a 96 well ELISA plate.
Results: Green tea had the highest inhibition on 4TI cells proliferation at a concentration of IC50 = 13.12 μg/ml. Further
analysis of the 4TI cancer cell line treated with tea using 454 pyrosequencing generated 425,696 reads with an input
mean length of 286.54. Trimmed sequences were imported on a CLC genomic workbench v7.03 and annotated on a
reference mouse genome (Mus musculus strain C57BL/6 J). Results revealed a differential expression of apoptosis related
genes in the transcriptome. Casp8, Casp9, Casp3, Casp6, Casp8AP2, Aifm1, Aifm2 and Apopt1 genes were significantly
upregulated indicating the process of apoptosis was initiated and executed.
Conclusion: These findings on caspases offer valuable information on the mechanism of tea as an anticancer agent and
will contribute to further research in future novel treatments.
Keywords: Catechins, Egcg, Theaflavins, Anthocyanins, Antioxidant activity, Caspases
Background
Tea, from (Camellia sinensis L.O Kuntze) is a widely
consumed beverage in the world. Phytochemicals and
functional components in tea are receiving a lot of atten-
tion due to their potential benefits in health when
consumed as part of a varied diet on a regular basis and
at effective levels. Many nutraceuticals, functional foods
and naturally occurring polyphenols have physiological
and pharmacological activities including their well
characterized antioxidant properties [1–3]. The scientific
and food industry communities share a common goal of
extending the quality of human life by utilizing phyto-
chemicals. The potential start point in this is through
development of viable options for the management of
chronic diseases through the use of nutraceuticals and
functional foods. This is because functional foods are
fairly affordable, readily available and extremely active,
have profound effect on cell metabolism and often dem-
onstrate few side effects [4]. It is evident that nutraceuti-
cals offer a selective advantage over synthetic drugs
necessitating need to investigate their usefulness to hu-
man health.
Tea is rich in polyphenols associated with numerous
pharmacological properties such as; antimicrobial [5],
anti-inflammatory [6], anti-aging [7, 8] antimalarial [9]
and antioxidant activity [1, 3, 10]. Cancer, accelerated
aging and other chronic disease associated with free
radical induced oxidative damage [4] can be ameliorated
by phytochemicals in tea since antioxidants in tea have
been shown to protect DNA from damage induced by
free radicals and slow or halt initiation and progression
of cancerous tumor growth [12]. Epicatechin gallate
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(EGCG) a polyphenol in tea, has been shown to inhibit
growth of cancer cells as well as play an important role in
stimulating apoptosis or programmed cell death both of
which are crucial aspects of cancer prevention [13, 14].
Biochemical actions of green tea and mainly the catechin
EGCG in chemoprevention and anticancer effect have
been studied by various reseachers [15–20]. Further, there
is also increasing evidence that tea provides significant
immuno-protective qualities to cancer patients undergo-
ing radiation and chemotherapy [19]. However, mecha-
nisms of action of anti-cancer properties are poorly
understood. Additionally, published data have primarily
focused on green tea yet black tea is the most widely con-
sumed tea product worldwide. Data on purple tea which
is a novel product rich in anthocaynins is also lacking.
This study set out to establish possible mechanisms
of cancer prevention by Kenyan green, black and purple
teas using the 4TI metastatic breast cancer model.
Gene expression profiles of the 4TI cancer cell line
were analyzed using the 454 pyrosequencer technique;
a fast, simple, and cost effective method of determining
candidate genes involved in major metabolic pathways.
The technology also provides a more comprehensive and
efficient way to measure transcriptome composition and
obtain RNA expression profiles [21]. In addition,
whole-genome sequencing and analysis of cancer and
matched normal genomes with next-generation se-
quencing platforms can illuminate commonly mutated
genes and transcript-level events that contribute to
the underlying cancer biology.
Methods
Test tea and cell culture samples
Test tea samples were sourced from farms of the Tea
Research Institute (TRI) (0°22′18.54″S, 35°21′3.19″E,
2180 m asl) in Kericho Kenya where tea is commercially
grown. The tea samples were obtained from fresh leaves
consisting youngest two leaves and a bud from tea
bushes. These samples were processed into black, green
or purple tea and stored in alunimium foils as detailed
in Karori, et al. [2] for use in analysis. Cell cultures (4TI
metastatic breast cancer cells) were obtained from the
Center for Traditional Medicine and Drug Research
(CTMDR), Kenya Medical Research Institute (KEMRI),
Nairobi, Kenya in cryopreserved form. The 4TI meta-
static breast cancer cells were maintained at pH 7.2 in
Minimal Essential Medium (MEM) (Invitrogen, Carlsbad,
CA, USA) supplemented with 2 mM L-glutamine, 5% fetal
calf serum (FCS) (Sigma, USA) and 2% penicillin-
streptomycin at 37 °C in humified incubator at 5%
CO2. Cells were grown in standard T75 tissue culture
flasks and upon reaching 80% confluence were passaged
with a solution of 0.25% trypsin-ethylene di amine tetra
acetic acid (EDTA). The cells were cultured for a maximum
of 10 passages after retrieval from the fresh cells in the
frozen stock.
Approval to conduct research on the 4TI cells culture
was obtained from KEMRI Institutional Ethical Review
Committee (protocol number SCC 2435) and National
Institute of Health (approval number 991073).
Assessment of tea infusions effects on growth and
proliferation of 4 T1 cells
Effects of black, green or purple tea infusions on viability
and proliferation of the 4 T1 cells was determined using
3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium-
bromide (MTT) salt assay (Roche Diagnostics GmbH,
Germany) as described in ATCC catalogue number 30-
1010 K. Samples and reagents were distributed in a
standard 96 wells plate in three independent replicates.
Then each plate was incubated for 24 h to permit the
cells to attach on surface of the respective wells in the
plate. All media were subsequently replaced by 150 μl of
black, green or purple tea (600 mg/ml) infusions in the
last row (Row H) in each plate. In order to obtain a
threefold dilution, serial dilution was carried out by re-
moving 50 μl from wells of row H and adding to wells of
row G. The contents were well mixed and 50 μl trans-
ferred from row F. This was continued upto row B
where 50 μl was discarded so as to leave row A intact.
Contents of the first row (row A) in each plate were exe-
mepted from the serial dilution procedures and therefore
acted as the negative controls for the wells challenged
with respective tea infusions. Each plate was incubated
at 37 °C, 5% CO2 for 48 h after which MTT (10 μl of
5 mg/ml stock solution in PBS was added into each well
and were subsequently further incubated at 37 °C for
2 h. Resultant purple precipitates of formazan in each
plate were dissolved in 150 μl of dimethyl sulfoxide
(DMSO). Absorbances of the contents of the wells
were recorded at 540 nm using Bio-Rad 3350 micro-
plate reader (Bio-Rad, Hercules, CA, USA) according
to the manufacturer’s instructions. The absorbances of
the experimental wells were used as an index proxy
for viability in relation to the readings absorbances of
the control wells that were representatives of 100%
viability.
Statistical analysis
Data obtained were expressed as mean ± SEM of repli-
cates and analyzed using the Alamarblue assay for IC50.
Comparison between data sets was performed using one
way analysis of variance (ANOVA) followed by Student’s
t-test. All statistical analyses were performed using
GraphPad Prism 5.0 (GraphPad Software Inc., San
Diego, CA). Differences were accepted as statistically sig-
nificant at p < 0.05.
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Cell harvesting for mRNA isolation
Cells at a density of 2.0 × 105 cells/ml were cultured in
T75 flask and allowed to attach for 24 h and at 70% con-
fluent, the cells were treated using green, black or purple
tea extracts at the respective IC50 obtained above. The
cultures were incubated at 37 °C in a humified incubator
at 5% CO2. After 24 h, the cells were then observed
under a microscope for morphological changes.
The media from the plate was discarded and 2xPBS
added to the flask for washing. A volume of 1 ml trypsin
was added to the flasks and cells incubated for 2 min to
allow for detachment. Soon after, the suspension was
pipetted into eppendorf tubes and centrifuged (Eppendorff
centrifuge 5810R, A-4-62 rotor) at 15000 rpm for 10 min
to remove the supernatant. The cells were washed in
1xPBS and centrifuged again at 1500 rpm for 3 min. New
PBS solution was then added to cover the cells; and the
cells were then frozen at -196 °C in liquid nitrogen for
mRNA isolation.
Extraction and quantification of mRNA
Extraction and quantification of mRNA was carried out
at the BecA-ILRI Hub laboratories after an ethical
approval by ILRI Institutional Research Ethics Commit-
tee (IREC) and given protocol number IREC2013–05.
Isolation of mRNA was carried out using mRNA isola-
tion kit Catalogue Number 11741985001 (Roche,
Germany) but with slight modification. In addition,
reference was made on work by Michaela, et al. [22] on
the utilization of paramagnetic particles. A cell density
of 1.0 × 107 cells/ml was used as the starting material.
The cells were washed three times in ice cold PBS and
spun at 15000 rpm for 3 min at 4 °C. A volume of 1 ml
of lysis buffer was added to the cells and vortexed for
15 s. DNA was mechanically sheared by passing the cells
10 times through a 21 gauge needle. Streptavidin-
coated–magnetic particles (SMPs) were re-suspended
thoroughly and 100 μl pipetted into fresh micro tubes.
The SMPs were immobilized on the side of the con-
tainer with a magnetic particle separator. The entire
storage buffer was removed and SMPs re-suspended in
500 μl of lysis buffer. The entire lysis buffer was re-
moved after immobilizing the SMPs with a magnetic
particle separator. A volume of 6 μl of Biotin-labeled
Oligo(dT) was added to the sample and mixed well to
form a hybridization mix. After a careful mixing, the
hybridization mix was added to the tube containing the
already prepared SMPs and re-suspended. The mixture
was incubated at 0 °C for 5 min followed by the separ-
ation of SMPs from the fluid for 30 min. The SMPs were
washed in 500 μl of wash buffer 5 times then the wash
buffer quantitatively discarded after the last washing
step. mRNA was eluted by adding 50 μl of double distilled
water to the SMPs and incubating for 2 min at 65 °C. The
mRNA was transferred to fresh define (RNase)-free tubes
and stored at -80 °C.
Purity and concentration of mRNA was assessed by
determining the absorbance of the sample at 260/280 nm
using a 2000-NanoDrop spectrophotometer (Thermo
Fisher Scientific-USA). The quality of the extracted mRNA
was also checked by electrophoresing it on a 2% agarose
gel. The samples were denatured by adding 5 μl of RNA
sample buffer (95% deionized formamide, 5 mM EDTA,
0.025 xylene cyanol FF, 0.025% bromophenolblue and
0.025% sodium dodecyl sulphate (SDS). The samples were
then put in a water bath at 65 °C for 5 min and immedi-
ately immersed in ice after the lapse of 5 min to avoid
renaturation. The total mixture was loaded on a 2%
agarose gel stained with 2.5 μl of (10,000×) GelRed and
electrophoresed for 25 min at 100 V.
Preparation of cDNA library for Transcriptome
sequencing
The cDNA library was synthesized using cDNA rapid
library preparation kit (GS FLX Titanium Series- 2010
Revised Edition, Roche (Germany) according to manu-
facturer’s instruction. The sample mRNA (200 ng) was
fragmented into smaller pieces at 70 °C for 30 s in the
fragmentation buffer (0.1363 g of ZnCl2, 1 M Tris-HCL
pH 7.0 and 1-10 ml of molecular grade water) and dena-
tured by adding Roche primers ‘random’ for 10 min at
70 °C. A volume of 2 μl of 0.5 M EDTA at a pH of 8.0
and 28 μl of 10 mM Tris HCL were added and mixed
with 80 μl of RNA clean reagent containing solid phase
reversible immobilization (SPRI) beads. The mixture was
mixed well at room temperature for 10 min then sepa-
rated using a 96 ring magnetic particle separator (MPC).
The beads were washed carefully using 200 μl of 70%
ethanol and the supernatant carefully discarded.
To the fragmented RNA, 4 μl of the random Roche
primer was added and vortexed for 10 s. With the tube
in ice, the fragments were reverse-transcribed to
synthesize first strand cDNA using avian myeloblastosis-
virus (AMV) reverse transcriptase (Roche, Germany) -μl
of 5xRT-buffer AMV, 4 μl of 0.1 M DTT, 4 μl of 10 mM
dNTPS, 1 μl of 25 U/μl protector RNase inhibitor and
2 μl of 25 U/μl AMV RT). Subsequently, the second
strand cDNA was synthesized using second strand
enzyme (Roche- 30 μl of 5 × 2 buffer, 72 μl redistilled
water, 1.5 μl of 10 mM dNTPs and 6.5 μl of a second
strand enzyme). The mixture was spun for 2 s and in-
cubated at 16 °C for 2 h before adding 20μlof T4 DNA
polymerase (Roche, Germany). The 1.7 ml contents
were transferred to a 2.0mlmicrocentrifuge and 300 μl
of AMPure beads added. The beads were separated
using a MPC and washed carefully using 70% ethanol.
The beads were allowed to air dry at room temperature
for 3 min, washed using 16 μl of 10 mM Tris-HCL,
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allowed to pellet and the pellets containing the ds-
cDNA transferred to a fresh 200 μl PCR tube.
The cDNA fragments were end repaired using an end
repair mix composed of 1 μl T4 DNA polymerase,
1μlTaq polymerase and 2.5 μl of polynucleotide kinase
buffer, 2.5 μl of ATP, 1 μl of dTNP) before ligation of
adaptors with multiplex identifier (MID) adaptor and
DNA ligase (Roche, Germany) at 25 °C for 25 min. The
products were purified to remove fragments less than
50 bp long using individual sample clean up (ISC) sizing
solution (Roche, Germany). The cDNA library was
then quantified and assessed for quality using TBS 380
Fluorometer(Turner Biosystems, USA) and Agilent bioa-
nalyzer high sensitivity DNA chip (Agilent Technologies,
Germany), respectively.
EmulsionPCR amplification
The emulsion PCR (emPCR) amplification was done
using the emPCR KitGS FLX Titanium series (Roche,
Germany). In brief, the adapter containing quality cDNA
was mixed with capture beads, PCR reagents and emul-
sion oil and run using the following program;1 × 94 °C
for 4 min, 50 × 94 °C for 30 s, 58 °C for 4.5 min, 68 °C
for 30 s, 10 °C on hold. After the PCR reaction the beads
were checked for emulsion breakage which is a distinct
layer with a clear middle layer. The broken emulsion
were discarded while intact emulsion were used for bead
recovery. Those beads that did not hold DNA were elim-
inated while beads holding more than one type of DNA
were recovered and washed. To ensure that only the
beads carrying the amplified DNA was used in the
sequencing, the recovered beads were enriched by
hybridization of the biotinylated enrichment primer to
the adaptor of each amplified DNA template to which
it is complemetary in its binding to streptavidin-coated
magnetic beads. The beads carrying the amplified
DNA were separated from the null and poorly ampli-
fied beads using a magentic particle separator. The
DNA library beads were separated from the magnetic
beads by melting the amplification products away from
the enrichment primer, leaving a population of bead-
bound single-stranded template DNA fragments which
are immobilized and amplified DNA library. The final
step in the emPCR amplification process was the
annealing of sequencing primer to the amplified DNA
template to form a library of clonally amplified DNA
fragments ready for loading onto a picoTiter plate and
sequencing.
454 sequencing
Sequencing was done from both the 5′ and 3′ end using
454 sequencing technology at the BecA-ILRI Hub for
the tea treated groups and the control group. Sequen-
cing was accomplished using a GS FLX Titanium
sequencing kit (Roche, Germany) according to the man-
ufacturers’ instruction. In brief, the DNA-capture beads
were loaded onto PicoTiterPlate™ such that each well
contained single DNA beads. Sequencing reagents com-
prising of deoxynucleotide triphosphate(dNTP) buffers,
sodium chlorite tablet, Apyrase, Ppiase, inhibitor TW re-
agent, enzyme beads, bleach and DTT were sequentially
flowed over the plate. The sequencer automatically per-
formed and monitored the sequencing reactions in all
the wells of the PicoTiterPlate simultaneously. The raw
output of a sequencing process consisted of a set of
digital images (PIF files) from which the sequence of the
DNA library fragments was read. The processing of
images to sequences and base-calling calculations were
all performed by the 454 data processing pipeline in
which raw reads were obtained.
Sequence analysis
Quality control and de novo assembly of sequencing
reads
Individual sequences from each treatment were extracted
and separated from the raw 454 reads ssf file based on their
unique multiplex Identifier (MID) sequence tag using sfffile
and converted into their respective fastq files using sffinfo
routines in Newbler v2.3 (Roche GS De Novo Assembler
v2.3; Roche Life Sciences, Inc.). Before assembly, the raw
reads were filtered using FASTX-tool kit to obtain the
high-quality clean reads by removing adaptor sequences,
duplication sequences, the reads containing more than 10%
“N” rate (the “N” character representing ambiguous bases
in reads), and low-quality reads with minimum length of 50
withquality score cut-off (Q-value <20) and minimum per-
centage of 75 (p75). The Q-value is the quality score
assigned to each base and was defined by the equation;
Q = − 10log10(e);
Where e is the probability of a base call being wrong.
The higher the score, the lower the probability of a
wrong base call during sequencing.
The sequences were again checked for data quality
using FASTQC (Babraham Institute, Cambridge, UK)
and imported into the CLC Genomics Workbench v7.03
software (CLC bio, Aarhus, Denmark) for post-processing
and data analysis. Briefly, the sequences were trimmed
based on the FASTQC report and were mapped onto
annotated mouse genes with support from reference
mouse (Mus musculus strain C57BL/6 J) genome and
transcript/mRNA from mouse using RNA-Seq routine.
All the mouse genome and annotations were obtained
from the mouse genome project (sanger.ac.uk/resources/
mouse/genomes). Using the trancripromic analysis routine
in the software, the data were normalized by total reads
per million and analyzed for differential gene expression
empirical analysis of differential gene expression subrou-
tine based on reads per kilobase of transcript per million
Mbuthia et al. BMC Complementary and Alternative Medicine  (2017) 17:202 Page 4 of 13
reads mapped (RPKM). Promising up and down regulated
candidate genes were selected on basis of a combination
of their RMPM, P-values and folds change values.
Results and discussion
4TI cell culture assay
The reduction in the viability and proliferation of
4T1cancer cells were determined using the3-(4, 5-di-
methylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide)
(MTT) assay. Results obtained in this in vitro toxicity
assay were analyzed and results presented in Fig. 1.
Green tea had the highest inhibition on cancer 4TI cells
at a concentration of IC50 = 13.12 μg/ml, black tea the
lowest at IC50 = 44.04 μg/ml and purple tea had an
inhibition of IC50 = 29.27 μg/ml. The inhibition on 4TI
cells by the teas analysed in this study was significantly
different (p ≤ 0.05).
Cancer cell concentration and viability in the presence of
the tea extracts were compared with that of the control and
the definition of cytotoxicity described by Malebo, et al.
[23] and Zofou, et al. [24]. The definition applied in this
study to rate cytotoxicity was as follows; IC50 < 1.0 μg/ml
(high toxicity); IC50 of 1-10 μg/ml (moderate toxicity): IC50
of 10-30 μg/ml (mild toxicity) and an IC50 > 30 μg/ml was
considered nontoxic. Based on this, green and purple teas
had a mild toxicity whereas black tea had no toxicity
towards the cells (Table 1).
Based on the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium (MTT) observation, the cells were
cultured in a T75 flask to score the effect of various teas
on cell growth. Results presented in Fig. 2 below clearly
shows that the 4TI cancer control cells after incubating
using 5% CO2 for 24 h in Davis Minimal Essential media
had their monolayer intact and the cells had attained a
confluence of over 90%.
However, when the 4TI cells were treated with black,
purple andgreen tea an effect on the cell viability and
proliferation was observed on the monolayer formation.
Results from this study revealed that tea had an effect
on cell growth by disrupting the monolayer formation
which was evidenced by a reduction in the cell to cell
contact and this was the reason why there was an ultimate
reduction in the spreading of the cells (Figs. 3, 4 and 5).
This remarkable observation was a clear indication that
tea inhibited cell viability and proliferation.
Chemo-prevention agents with anticarcinogenic prop-
erties impact on cell populations by reducing, cell
viability and proliferation. A reduction in cell prolifera-
tion rate indicates that there is a reduction in cell
viability and the ensuing metabolic events that leads to
apoptosis and necrosis. For the first time, this study
attempted to determine the chemo-preventive effects of
green tea, black tea and purple tea extracts in a highly
metastatic breast cancer 4TI cell line in vitro. In this
assay the tea extracts caused a reduction in cell prolifer-
ation since the absorbance values of cells treated with
tea extracts were lower than those of the control. This
was caused by a reduction of the yellow tetrazolium salts
by metabolically active cells in part due to the action of
dehydrogenase enzymes to generate reducing equiva-
lents such as NADH and NADPH.
Dysregulated proliferation in cells appears to be a
hallmark of susceptibility to neoplasia and its regulation
is critical in the prevention of cancer. The process of
cancer prevention is generally associated with inhibition,






























Fig. 1 Quantification of the inhibitory concentration (IC50 μg/ml) of purple, black and green teas on 4TIcancer cells
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and most flavonoids have been demonstrated to inhibit
proliferation in many kinds of cultured human cancer
cell lines [25, 26] with no similar cytotoxicity to human
normal cells. Researchers have conducted in vitro bioas-
says on the potential anticancer activity of flavonoids in
diverse cell systems. Hirano, et al. [27] examined anti-
cancer efficacy of 28 flavonoids on human acute myeloid
leukemia cell line HL-60, and compared differences
between anti-proliferative activity and cytotoxicity of
these compounds with those of four clinical anticancer
agents. From his work, eight of the 28 flavonoids showed
considerable suppressive effects on HL-60 cell growth
with IC50 values ranging from 10 to 940 ng/ml. The
lavonoid genistein had the strongest effects almost
equivalent to the effects of current anticancer agents
with little cytotoxicity against HL-60 cells, whereas the
regular anticancer agents had potent cytotoxicity. Kuntz,
et al. [25] screened more than 30 flavonoids to establish
their effects on cell proliferation and potential cytotox-
icity in human colon cancer cell lines Caco-2 and
HT-29. He found out that nearly all compounds
displayed anti-proliferative activity without cytotoxicity.
Maricela and Walle, [26] examined the effects of querte-
cin (3, 5, 7, 3′, 4′-pentahydroxyflavone), a major dietary
flavonoid, on cell growth and necrosis using oral squa-
mous carcinoma SCC-9. Quercetin is the most abundant
molecule in the extensive class of polyphenolic flavo-
noids ubiquitously found in plants and in many often-
consumed foods, such as apples, onions, tea, berries,
among others [28]. From their study, quercetin was ini-
tially shown to induce a stress response, resulting in ne-
crosis of these oral epithelial cells. However, a prolonged
exposure of the remaining cells to quercetin induced an
apoptotic effect. The molecular properties underlying
these effects were attributed to a wide array of biochem-
ical mechanisms, including antioxidant properties [29]
and effects on enzymes and signal transduction path-
ways involved in cell proliferation, cell cycle regulation
and apoptosis [30].
Table 1 Cytotoxicity of various tea extract
Tea samples
Green tea Black tea Purple tea
IC50 (μg/ml) 12.55 50.66 32.96
14.25 38.49 28.13
12.56 42.96 26.73
Mean (μg/ml) 13.12 44.04 29.27
Toxicity level Mild Non toxic Mild
n 3 3 3
CV 7.46% 13.98% 11.17%
Fig. 2 A monolayer of 4TI control cells after 48 h in DMEM media
Fig. 3 Sensitivity of 4TI cancer cells to black tea at IC50 of 44.04 μg/ml
showing disruption of monolayer
Fig. 4 Sensitivity of 4TI cancer cells to purple tea at IC50 of 29.27 μg/ml
showing disruption of monolayer
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The encouraging results of anticancer effects in
preclinical studies have in the recent past stimulated the
clinical trials of flavonoids in human. Wang, [31] exten-
sively reviewed the therapeutic potential in human of
four most widely investigated flavonoids namely flavopir-
idol, catechins, genistein and quercetin and found out
that flavopiridol had achieved a proof-of-concept in
phase I/IIa trials as a monotherapy. Mohbound and
Khorshid, [32] studied the role of green tea polyphenols
on the proliferation of human ovarian cancer cells in
vitro and found out that green tea extract caused a
reduction in cell proliferation. The inhibitory effect was
attributed to the presence of 3–0-gallate group of the
catechin structure which is a very efficient antioxidant
[20]. Since green tea is rich in catechins, this explains
why the activity of green tea in this study was higher
than that of black and purple teas. During the processing
of black tea, catechins as explained earlier are converted
to highly polymerized substances namely TFs and TRs
which have a lower antioxidant activity compared to
green tea catechins.
Dietary flavonoids like those found in tea are natural
antioxidants [1, 7, 11] that act by limiting the damaging
oxidative reactions in cells, which may predispose cells
to the development of cancer [33–35]. Oxygen-derived
free radicals appear to possess the propensity to initiate
as well as to promote carcinogenesis [36]. Chemically,
flavonoids are capable of being one-electron donors and
therefore serve as derivatives of conjugated ring struc-
tures and hydroxyl groups that have the potential to
function as antioxidants in in vitro cell culture or cell
free systems thereby scavenging superoxide anion,
singlet oxygen, lipid peroxy-radicals and/or stabilizing
free radicals involved in oxidative processes through hy-
drogenation or complexing with oxidizing species [37].
In vitro studies are able to demonstrate this activity for
flavonols, flavones and most recently also for anthocya-
nins with the predominant anthocyanidin being malvidin
[10, 38]. A correlation analysis between the different
biochemical parameters in purple teas and antioxidant
capacity has revealed that some anthocyanin/anthocyani-
din fractions are individually and collectively potent
anti-radical molecules. The molecules identified by
Kerio, et al. [10, 38] included cyanidin- 3-O-galactoside,
cyanidin-3-O-glucoside, peonidin and malvidin. Just like
the catechins, the antioxidant efficiency of anthocyanins
is related to several parameters which include the num-
ber of hydroxyl groups in the molecule, the catechol
moiety in the B-ring, the oxoniumion structure in the C-
ring, the hydroxylation and methylation pattern and to
the acylation by phenolic acids [39]. Studies on the
antioxidant activities of other beverages like wines have
also revealed that glycosylated and methoxylated antho-
cyanins such as cyanidin-3-O-glucoside and malvidin-3-
O-glucoside which are predominant in red wines are
responsible for the antioxidant effect of red wine [40].
A study to determine the quenching of singlet molecu-
lar oxygen (1O2) by the flavylium cation revealed that
the quenching efficiency was larger for the malvidin
derivative, probably due to the electron donating meth-
oxyl group in the B-ring of the malvidin molecule [40].
Further, it can also be deduced that the high antioxidant
activities exhibited by the purple leaf coloured anthocya-
nin rich teas could be due to the catechin–anthocyanin
complexes that are believed to have additional hydroxyl
groups necessary for free radical-scavenging activity.
This antioxidative activity of polyphenols found in pur-
ple tea can be used to explain why purple tea exhibited
an activity against the 4TI cancer cells.
Lee, et al. [41] used 4TI cancer cells in vivo to explain
why resveratrol (trans-3,4′,5-trihydroxystilbene) a natur-
ally occurring polyphenolic phytoalexin that is present in
abundance in many fruits, such as grapes, as well as in
wine affects metastasis in breast cancer. Lee’s, [41] study
was the first to report that oral administration of resver-
atrol inhibited the metastasis and growth of 4T1cancer
cells to the lungs in a BALB/c murine model of experi-
mentally induced cancer. Based on these findings, he
confirmed that resveratrol may inhibit metastasis by
decreasing the activity and expression of MMP-9 a family
of enzyme related to tumor invasion and metastasis.
However, despite a number of findings on in vitro an-
ticancer property of tea extracts, there is lack of infor-
mation on the exact molecular mechanism of anticancer
activity of tea. In addition, much work has been carried
out using green tea which is mainly consumed in Asia
but none on black tea which is the principle tea product
from Kenya and also the recently produce purple tea. To
further establish why cell viability was reduced in the
Fig. 5 Sensitivity of 4TI cancer cells to green tea at IC50 of 13.12 μg/ml
showing disruption of monolayer
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4TIcancer cell line, RNA was extracted from the cells for
gene expression profiling to elucidate the underling mo-
lecular response of cancer cells to administered tea.
Quantification and assessment of mRNA quality
The quality and quantity of total mRNA isolated from
the 4TI cancer cells was determined using a Nanodrop
2000 spectrophotometer. A ratio of the optical absorb-
ance at 260 nm and 280 nm (A260/280) was used to
evaluate for residual contamination of proteins. The
ratios obtained in this study indicated that the isolated
RNA was of the desired quality since the values ranged
between 1.76 and 2.08 (Table 2).
The intactness of the mRNA was determined by agarose
gel electrophoris. The electrophoresed mRNA formed a
smear with two faint bands which indicated that it was not
degraded and therefore the extraction procedure had been
successful in delivering intact mRNA (Fig. 6). An intact
mammalian poly (A) + RNA appears as a smear sized from
0.1 to 4-7 kb or more with faint 28S and 18S rRNA bands.
cDNA synthesis
cDNA libraries were synthesized from the isolated
mRNA and the quality of the cDNA synthesized
assessed using a DNA chip. A peak which ranged
between 600 and 1200 bp was produced (Fig. 7). A gel
like image presentation of the same also produced a
thick band at the same fragment length as Fig. 8 which
was within the required range for good quality cDNA.
De novo sequencing of the 4TI coding transcriptome
After the removal of low quality reads, adaptors and
sequences less than 50 bp, the quality checks using
FastQc showed that all the sequences had a Phred-like
quality scores greater than Q20 level (an error
probability of 0.01) (Fig. 9). This meant that there was
minimal chance of a base being called incorrectly.
Functional annotation
Mapping of the sequences, processed based on FastQC re-
port, onto the reference mouse genome (Mus musculus
strain C57BL/6 J) and subsequent differential gene expres-
sion analyses revealed green, black and purple tea extracts
specific responsive genes in the 4TI cancer cells. All the
extracts, described earlier in the cytotoxicity assay, inhib-
ited cell proliferation relative to the control, as revealed by
differential expression of apoptosis related gene family in
the transcriptomes. Apoptosis is a critical defense against
hyperproliferation of cancer [42] with the results poten-
tially indicative of reduced cell viability with ensuing meta-
bolic processes potentially precipitating apoptosis and
necrosis. This is further underpinned by significant induc-
tion of caspases namely casp8 and casp8AP2 in this study
(Table 3) which are established executioners of apoptosis
cascades. Since caspases are encoded by cysteine-aspartic
acid and act as mediators of apoptosis [43], their signifi-
cant up regulation in black, green and purple tea treated
cell-lines, relative to control indicates induction of apop-
tosis which is a vital step in fighting cancer manifestations.
These finding are in concert with and shed light on poten-
tial mechanism of the anti-cancer properties of tea poly-
phenols, as apoptosis related to induction of casp8 gene
initiates the apoptotic pathway [44–46].
The possible mechanism through which the green,
black and purple tea induced anticancer responses in
this study was through the induction of casp3 and
casp6 genes which indicated potential cleavage of
equally induced caspase-8, a component of the extrin-
sic apoptotic pathway as has been described by Orbest,
[47]. Additionally, the significant up regulation of
Table 2 The concentration and quality of mRNA as determined based on absorbance at 260 nm and 280 nm using a Nanodrop
spectrophotometer
# Sample ID Nucleic acid conc. (ng/μl) Unit A260 A280 260/280 MIDa
1 GT-B 234.3 ng/μl 7.101 3.406 2.08 13
2 CC-B 279.1 ng/μl 8.457 4.119 2.05 14
3 D-B 36.5 ng/μl 1.107 0.598 1.85 15
4 PT-C 94.9 ng/μl 2.876 1.513 1.9 16
5 GT-D 130.3 ng/μl 3.948 2.11 1.87 17
6 BT-C 66.2 ng/μl 2.008 1.022 1.96 18
7 BT-D 88.1 ng/μl 2.67 1.412 1.89 19
8 PT-A 181.7 ng/μl 5.507 2.749 2 20
9 PT-D 80.3 ng/μl 2.432 1.192 2.04 21
10 GT-A 38.7 ng/μl 1.172 0.579 2.02 22
11 CC-C 12.6 ng/μl 0.382 0.189 1.76 23
aMultiplex Identifier (MID) stands for multiplex identifier which is a 10 nucleotide identifier sequence for differentiation of multiplex sequence data sets
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casp8AP2 in this study suggests that the extrinsic
pathway was initiated. This gene has been shown to be
an apoptotic protein which interacts with the death-
effector domain (DED) of caspase 8, a component of
the death inducing signaling complex. Induction of
this pathway has been associated with release of cyto-
chrome c, which was putatively activated as evidenced
by the significant induction of Apopt1, Aifm1 and
Aifm2 genes. The Apopt1 mediate mitochondria-
induced cell death through the release of cytochrome
c and activation of the caspase cascade [46]. The
Aifm1 and Aifm2, induce mitochondria to release
apoptogenic proteins, cytochrome c and caspase 9. In
this study Casp9 was significantly up regulated, a clear
indication that the process of apoptosis was executed
(Table 3).
Most phytochemicals for example curcumin, thesinen-
sin, resveratrol, acecetin and sulforaphane have been
shown to work based on this pathway. Curcumin (difer-
uloylmethane), the yellow pigment in the rhizome of
turmeric (Curcuma longa) has been shown to induce
apoptosis in several types of cancers including prostate,
breast, colon and leukemia through the mitochondrial
pathway that involvescaspase-8, BID cleavase, cyt-c re-
lease and caspase-3 activation. BCL-2 and BCL-XLare




IKb+ CC-B GT-B GT-D        PT-A      PT-D BT-D BT-C
Fig. 6 Gel electrophoresis image of mRNA from cells treated with the representative tea samples
Fig. 7 Representative images indicating the size distribution and quality of cDNA library assessed on an Agilent bioanalyzerhigh sensitivity DNA
chip. The cDNA produced a peak between 600 and 1200 bp as shown by the arrow
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oolong tea has also been shown to induce apoptosis
through the elevation of ROS production, release of
cyt-c, followed by the concomitant induction of caspase-9.
Most phytochemicals for example curcumin, thesinen-
sin, resveratrol, acecetin and sulforaphane have been
shown to work based on this pathway. Curcumin (difer-
uloylmethane), the yellow pigment in the rhizome of
turmeric (Curcuma longa) has been shown to induce
apoptosis in several types of cancers including prostate,
breast, colon and leukemia through the mitochondrial
pathway that involvescaspase-8, BID cleavase, cyt-c re-
lease and caspase-3 activation. BCL-2 and BCL-XLare
critical regulators of curcumin [48].Thesinensin-A from
oolong tea has also been shown to induce apoptosis
through the elevation of ROS production, release of cyt-
c, followed by the concomitant induction of caspase-9.
Theaflavins (TF-1 and TF-2) from tea have also been
demonstrated to be effective on acute T -cell leukemia
and cause a rapid induction of caspase-3 but not
caspase-1 [49]. Sulforaphane (SFN) from criciferous
Fig. 8 Gel-like image of the cDNA library samples as run on an Agilent bioanalyzer high sensitivity DNA chip. The samples produced a smear that

















Fig. 9 Box plot showing quality scores of trimmed sequences
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plants like broccoli, cabbage, cauliflower and their
sprouts causes G2/M–phase arrest and increases apop-
totic cell fraction in leukemia cells, markedly increasing
P53 and Bax expression [50]. SNF brings growth inhib-
ition by inhibition of CDK-4 and CyclinD1 resulting in
G1/S cycle arrest with a down expression of BCL2 [51].
Styrylpyrone derivatives (SPD) from Goniothalamus sp.
inhibit proliferation and induce apoptosis in MCF-7
breast cancer cell line by increasing BAX level and Cas-
pase–9 which in turn activates executionercaspase-7 to
bring about apoptosis [52]. Resveratrol, a phytoalexin in
the red grape skin (Vitis vinifera) acts as an estrogen re-
ceptor (ER) agonist and suppresses proliferation by ER
independent pathway by inducing up regulation of P21
and brings about growth arrest [53]. At high concentra-
tions it inhibits Cyclin-D and CDK4 and upregulates P53
and P21 to bring about apoptosis. In MCF-7 breast
cancer cell line, it activates Caspase-9 and increases
BAX, BAK while decreasing BCL-2 and BCL-XL [54].
Acacetin, a flavonoid of Cirsium rhinoceros (Composi-
tae), induces the death receptor pathway by activating
Caspase-8 pathway both in HepG2 and A549 cells [55].
It is worth noting that the observed action of tea on
caspases through the intrinsic and extrinsic pathway
may offer valuable information since commonly used
drugs in cancer therapy and management operate based
on similar mechanisms. For example, the drugs Cis-
platin, Doxorubicin and Methothrexate all up regulate
the intrinsic pathway [56, 57] while on the other hand
the intrinsic pathway is induced by ionizing radiation
and also by chemotherapeutic agents [58]. Since conven-
tional radiotherapy and chemotherapy with synthetic
drugs evoke severe side effects including immunosup-
pression and in a majority of cases organ failure, edible
phytochemicals such as polyphenols in tea which are in-
expensive, effective, readily available and acceptable may
offer an alternative approach to caner control and man-
agement. This approach has however been constrained
by lack of adequate information on the distinct mechan-
ism of action of the tea phytochemicals. The results
obtained from this study on tea and apoptosis offer a
better understanding of teas mode of action on cancer.
It is anticipated that the information will contribute to
the body of knowledge that is necessary for the develop-
ment of safe multi-targeting anticancer drugs from nat-
ural dietary phytochemicals. The findings on the action
of tea on caspases offers valuable and insightful informa-
tion since commonly used cancer drugs operate based
on similar mechanisms.
Conclusion
The chemo-preventive effects of green tea, black tea and
purple tea extracts in a highly metastatic breast cancer
4TI cell line in vitro was carried out for the first time in
this study. Tea was demonstrated to be a chemo-
prevention agent with anti-carcinogenic properties that
impact on cell populations by reducing, cell viability and
proliferation. Mapping of the sequences obtained from the
454 pyrosequencing platform onto the reference mouse
genome Mus musculus strain C57BL/6 J and subsequent
differential gene expression analyses revealed that green,
black and purple tea extracts had specific responsive genes
in the 4TI cancer cells. The following genes were differen-
tially expressed; casp8, casp8ap2, casp3, casp6, apopt1,
aifm1, aifm2 and casp9.The mechanism through which
the green, black and purple tea induced anti-cancer
responses in this study was through the induction of
caspases which induced the apoptotic pathway.
Recommendations
Polyphenols in tea can be extracted and marketed as
pharmacological compounds with anti-cancer activity
thus expanding the uses of tea. The possible mecha-
nisms of protection by tea polyphenols against mutagens
has been reported in this study, however, further re-
search is needed to determine the mechanism of this
action in more details, and to explore other beneficial
effects that these polyphenols may have, before they can
Table 3 Transcriptome analysis of genes affected by green,
black and purples teas
Gene ID Green tea Black tea Purple tea








































































Legend; R; Stands for RPKM which are the reads per kilobase per million is a
method of normalization that is wizdely used in RNA-seq analysis
F; Stands for a fold change which is an algorithm used to produce biologically
meaningful rankings of differentially expressed genes from RNA-seq data
P; This is a probability of obtaining the observed effect under a hypothesis
(null). P value of less than 0.05 (p ≤ 0.05) are considered statistically significant
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be adopted for therapeutic use. Using edible or edible-
like plants compounds for example tea that has active
constituent in our daily life could be the best inexpen-
sive choice for protecting us from cancer. There is need
to undertake further studies and fully elucidate the
plausible mechanisms of tea antimutagenic and antican-
cer activity. Caspases and apoptotic pathway should be
used in investigating plant compounds with anti cancer
activity for drug development. We therefore recommend
the use of next generation sequencing platforms to
investigate the potential health properties of tea poly-
phenols and to support research focused on discovery of
new natural compounds which could help a lot in inves-
tigating or discovery new medicinal drugs especially
cancer drugs.
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